---
title: "Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292533332.md"
description: "Corbus Pharmaceuticals (CRBP) shares fell 6.61% to $9.04 on Monday, underperforming competitors like Vanda and Viking Therapeutics during a broader market decline. The drop ended a four-day winning streak, with the stock trading 56% below its 52-week high. Trading volume was notably lower than the 50-day average."
datetime: "2026-07-13T21:21:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292533332.md)
  - [en](https://longbridge.com/en/news/292533332.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292533332.md)
generator: "portal-rs"
---

# Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) slid 6.61% to $9.04 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.55% to 25,873.18 and Dow Jones Industrial Average falling 0.26% to 52,498.64.

The stock's fall snapped a four-day winning streak.

Corbus Pharmaceuticals Holdings Inc. closed 56.03% below its 52-week high of $20.56, which the company achieved on October 20th.

The stock underperformed when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. (VNDA) fell 3.85% to $6.00, Fortress Biotech Inc. (FBIO) remained unchanged, and Viking Therapeutics Inc. (VKTX) fell 1.90% to $38.12.

Trading volume (362,753) remained 188,167 below its 50-day average volume of 550,920.

Data source: Dow Jones Market Data, FactSet. Data compiled July 13, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-13-26 1721ET

### Related Stocks

- [CRBP.US](https://longbridge.com/en/quote/CRBP.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [VNDA.US](https://longbridge.com/en/quote/VNDA.US.md)
- [FBIO.US](https://longbridge.com/en/quote/FBIO.US.md)
- [VKTX.US](https://longbridge.com/en/quote/VKTX.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)
- [FBIOP.US](https://longbridge.com/en/quote/FBIOP.US.md)

## Related News & Research

- [Corbus Pharma CFO Sean Moran sells 12,000 shares for $120,971](https://longbridge.com/en/news/295447150.md)
- [Corbus Pharma CMO Nicacio Leonardo Viana files initial beneficial ownership statement](https://longbridge.com/en/news/294867785.md)
- [BUZZ-Mid-cap drugmakers face limited impact from Trump drug pricing deals, analysts say](https://longbridge.com/en/news/297637201.md)
- [Apnimed, Inc.'s Quiet Period Will End  on September 9th (NASDAQ:APMD)](https://longbridge.com/en/news/297735393.md)
- [Corbus Chief Business Officer Nishant Saxena acquires 2,600 shares worth $25,037.44](https://longbridge.com/en/news/295706183.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**